REGISTER
Practical treatment strategies for HER2-positive early breast cancer
Prof. Tao, Prof. Curigliano and Prof. Hu discussed practical treatment strategies for HER2-positive early breast cancer.

Prof. Zhonghua Tao, Fudan University Shanghai Cancer Center, China
Prof. Giuseppe Curigliano, European Institute of Oncology, Italy
Prof. Xichun Hu, Fudan University Shanghai Cancer Center, China


Prof. Tao, Prof. Curigliano and Prof. Hu discussed practical treatment strategies for HER2-positive early breast cancer, with a focus on the use of T-DXd in the post-neoadjuvant adjuvant setting. The discussion covered the possibility of de-escalating T-DXd treatment duration in patients with a low residual cancer burden, the management of patients who are unable to complete the full planned course of therapy, and the potential integration of novel endocrine therapies such as giredestrant into adjuvant treatment strategies.

0
0
Loading